The World's Leading Killer: Tackling Cardiometabolic and Non-Communicable Disease

Executive Summary

Non-communicable diseases (NCDs) — cardiovascular disease, cancers, diabetes, and chronic respiratory disease — are the leading cause of death on the planet, killing roughly 43 million people a year. Cardiovascular disease alone accounts for around 19 million deaths. Once thought of as "diseases of affluence," NCDs are now rising fastest in low- and middle-income countries, where prevention and chronic-care systems are weakest. Cost-effective interventions exist, but global resourcing — though large in absolute terms — is badly skewed away from the places bearing the heaviest burden.

The Scale of the Problem

The WHO reports that NCDs killed at least 43 million people in 2021 — 75% of all non-pandemic deaths — with cardiovascular disease responsible for at least 19 million. Roughly 77% of NCD deaths occur in low- and middle-income countries, and a substantial share are premature (under age 70).

A Distinct Problem from Infectious Global Health

While infectious disease control targets specific pathogens with tools like bednets and vaccines, the NCD challenge is one of chronic risk factors and lifelong care: hypertension, tobacco, harmful diet, physical inactivity, and alcohol, managed over decades. The intervention models, metrics, and health-system requirements are fundamentally different.

Why This Is Tractable (But Hard to Deliver)

The WHO's "best buys" are highly cost-effective:

• Tobacco, alcohol, salt, and sugar taxation and regulation.
• Hypertension control through low-cost generics in primary care.
• Statins and cardiovascular risk management for high-risk patients.

The difficulty lies in durable behavior change and delivering chronic care at scale through weak health systems — a harder operational challenge than one-time interventions.

The Neglectedness Reality

Globally, NCDs attract vast clinical, pharmaceutical, and research resources (cardiology, oncology, diabetes care), so total resourcing is large. But it is badly mismatched: only about 0.11% of development assistance for health reaches NCDs, despite roughly 77% of NCD deaths occurring in low- and middle-income countries. The neglect is in global health equity, not in absolute rich-world spending.

Recommendations

1. Scale WHO "best buys" — especially salt reduction, tobacco control, and hypertension management — in LMICs.
2. Redirect development health funding toward the vast underserved NCD burden.
3. Integrate NCD care into primary health systems rather than vertical programs.
4. Prioritize cardiovascular disease as the single largest component.

Further Reading

• WHO, Noncommunicable Diseases Fact Sheet (2021) and "Best Buys"
• Global Burden of Disease (IHME) NCD estimates
• NCD Countdown 2030, The Lancet
• Lancet Taskforce on NCDs and economics